Skip to main content
Log in

Sensitivity of lewis lung carcinoma to cisplatin undergoes considerable variations during growth and metastasizing

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Growth and metastasizing of Lewis lung carcinoma were accompanied by complex changes in tumor sensitivity to cisplatin. On day 17 of growth, tumor sensitivity was much lower than immediately after transplantation. Further growth of Lewis lung carcinoma was accompanied by a progressive increase in its sensitivity to cytostatic treatment. The study of migration activity of the tumor and dynamics of metastasizing showed that metastatically active carcinoma cells dominated on day 17 of tumor growth, but then the number of these cells progressively decreased to the 29th day of tumor growth. Growth-related changes in the sensitivity of Lewis lung carcinoma were probably due to complex variations in the number of metastatically active tumor cells with high resistance to cisplatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. C. Bell, P. Frost, and R. S. Kerbel,Cancer Genet. Cytogenet.,54, No. 2, 153–161 (1991).

    Article  PubMed  CAS  Google Scholar 

  2. M. L. Den Boer, R. Pieters, and A. J. Veerman,Leukemia,12, 1657–1670 (1998).

    Article  Google Scholar 

  3. R. S. Kerbel, H. Kobayashi, and C. H. Graham,J. Cell. Biochem.,56, 37–47 (1994).

    Article  PubMed  CAS  Google Scholar 

  4. A. V. Kolobov, A. A. Polezhaev, and G. I. Solyanik,J. Theor. Med.,3, 63–77 (2000).

    Google Scholar 

  5. J. T. Leith, P. Heyman, J. K. DeWyngaert,et al., Cancer Res.,43, 3240–3246 (1983).

    PubMed  CAS  Google Scholar 

  6. Y. Liang, S. McDonnell, and M. Clynes,Cur. Cancer Drug Target,2, No. 3, 257–277 (2002).

    Article  CAS  Google Scholar 

  7. T. Mosmann, J. Immunol.,Methods,65, Nos. 1–2, 55–63 (1983).

    CAS  Google Scholar 

  8. G. L. Nicolson and A. S. Moustafa,In Vivo,12, No. 6, 579–588 (1998).

    PubMed  CAS  Google Scholar 

  9. J. W. Rak and R. S. Kerbel,In Vitro Cell Dev. Biol. Anim.,29A, No. 9, 742–748 (1993).

    Article  PubMed  CAS  Google Scholar 

  10. G. I. Solyanik,The Physics of the Alive,6, No. 2, 59–64 (1998).

    Google Scholar 

  11. W. F. Symmans, J. Liu, D. V. Knowles, and G. Inghirami,Hum. Pathol.,26, No. 2, 210–216 (1995).

    Article  PubMed  CAS  Google Scholar 

  12. D. Theodorescu, I. Cornil, C. Sheehan,et al., Int. J. Cancer,47, 118–123 (1991).

    Article  PubMed  CAS  Google Scholar 

  13. Yu. R. Yakshibaeva, O. N. Pyaskovskaya, G. I. Solyanik, and V. F. Chekhun,Exp. Oncol.,24, 155–156 (2002).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. I. Solyanik.

Additional information

Translated fromByulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 138, No. 9, pp. 333–336, September, 2004

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solyanik, G.I., Garmanchuk, L.V., Pyaskovskaya, O.N. et al. Sensitivity of lewis lung carcinoma to cisplatin undergoes considerable variations during growth and metastasizing. Bull Exp Biol Med 138, 295–297 (2004). https://doi.org/10.1007/BF02694183

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02694183

Key Words

Navigation